Helix Acquisition Corp. III Receives Nasdaq Notice for Listing Deficiency

What Happened

• On August 14, 2026, Helix Acquisition Corp. III (HLXC) received a written notice from the Nasdaq Listing Qualifications Department stating the company is not in compliance with Nasdaq Listing Rule 5452(a)(2)(A), which requires at least 300 Total Holders for continued listing on the Nasdaq Global Market.
• The notice is a deficiency notification (required to be disclosed under Nasdaq Listing Rule 5810(b)), not an immediate delisting; as of August 17, 2026 HLXC’s Class A ordinary shares continue to trade on Nasdaq under the symbol “HLXC.”

Key Details

• Notice date: August 14, 2026; Form 8‑K filed August 17, 2026.
• Listing rule cited: Nasdaq Rule 5452(a)(2)(A) (minimum 300 Total Holders).
• Company has 45 calendar days from the notice to submit a plan to regain compliance.
• If Nasdaq accepts the plan, the company may be granted up to 180 calendar days from the notice date to evidence compliance; if Nasdaq rejects the plan, the company may appeal to a Nasdaq Hearings Panel.

Why It Matters

• For investors, this filing signals a formal deficiency that could lead to delisting proceedings if not remedied, though trading continues for now. The company notes there is no assurance it will regain compliance within any cure period and expressly warns of potential adverse effects, including stock‑price volatility. HLXC says it will monitor holder counts and consider available options to regain compliance.